Share ownership QuidelOrtho Corporation

QDEL

US2197981051

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 21:00:00 20/04/2026 BST			5-day change	1st Jan Change
12.89 ^USD	+1.42%		-19.84%	-54.87%

04-20	QuidelOrtho Completes Acquisition of LEX Diagnostics for $100 Million	MT
04-16	Top Midday Decliners	MT

Share class: QuidelOrtho Corporation

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	67,256,717	66,272,267 ( 98.54 %)	0	98.54 %

Major shareholders: QuidelOrtho Corporation

Name	Equities	%	Valuation
T. Rowe Price Investment Management, Inc. 17.43 %	11,832,098	17.43 %	194 M $
BlackRock Advisors LLC 14.34 %	9,735,197	14.34 %	160 M $
Vanguard Fiduciary Trust Co. 11.15 %	7,572,075	11.15 %	124 M $
T. Rowe Price Investment Management, Inc. 8.291 %	5,629,965	8.291 %	93 M $
Fidelity Management & Research Co. LLC 7.983 %	5,420,218	7.983 %	89 M $
Rubric Capital Management LP 5.563 %	3,777,157	5.563 %	62 M $
Invesco Advisers, Inc. 5.111 %	3,470,656	5.111 %	57 M $
Newtyn Management LLC 4.44 %	3,014,595	4.44 %	50 M $
DFA Australia Ltd. 4.06 %	2,756,706	4.06 %	45 M $
STATE STREET CORPORATION 3.983 %	2,704,355	3.983 %	44 M $
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	116.58%
Other	8.07%
State Street Corp.	3.98%
Silvercrest Asset Management Group, Inc.	1.59%
Individuals	1.04%
SEI Investments Co.	0.31%
Schweizerische Nationalbank	0.2%
Manulife Financial Corp.	0.04%
Governments	0.03%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	120.51%
Australia	4.08%
United Kingdom	3.31%
Canada	1.22%
Individuals	1.04%
Netherlands	0.68%
Monaco	0.3%
Switzerland	0.23%
Ireland	0.2%
Norway	0.09%
Sweden	0.06%
Germany	0.06%
Luxembourg	0.06%

Based on 1000 largest holdings

QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.

Employees

6,500

Sector

Advanced Medical Equipment & Technology

Calendar

05-05 - Earnings release - Q1 2026

More about the company